Ultragenyx to Host Conference Call for Third Quarter 2025 Financial Results and Corporate Update

(NASDAQ:RARE), NOVATO, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Tuesday, November 4, 2025, to discuss its financial […]

SS Innovations Reports Third Quarter 2025 Financial Results

SS Innovations Reports Third Quarter 2025 Financial Results Quarterly Revenue Increased 192.5% Year over Year to $12.8 Million Driven by Higher SSi Mantra 3 Unit Sales GlobeNewswire October 28, 2025 FORT LAUDERDALE, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) — SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical

Miluna Acquisition Corp Announces Closing of Full Underwriters’ Over-Allotment Option in connection with its Initial Public Offering

Miluna Acquisition Corp Announces Closing of Full Underwriters' Over-Allotment Option in connection with its Initial Public Offering GlobeNewswire October 28, 2025 Taipei, Taiwan., Oct. 28, 2025 (GLOBE NEWSWIRE) — Miluna Acquisition Corp (Nasdaq: MMTXU) (the “Company”), a Cayman Islands exempted company, announced today that the underwriters of its previously announced initial public offering fully exercised

Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients

Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients Akebia does not expect to initiate VALOR clinical trial following Type C meeting feedback from U.S. FDA GlobeNewswire October 28, 2025 CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) — Akebia Therapeutics(R), Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people

Business First Bancshares, Inc. Announces Stock Repurchase Program

Business First Bancshares, Inc. Announces Stock Repurchase Program GlobeNewswire October 28, 2025 BATON ROUGE, La., Oct. 28, 2025 (GLOBE NEWSWIRE) — Business First Bancshares, Inc. (Nasdaq: BFST) (Business First), the holding company for b1BANK, announced today that its Board of Directors has approved a stock repurchase program authorizing the company to repurchase shares of its

Comstock Inc. to Attend the 51st Annual New Orleans Investment Conference

Comstock Inc. to Attend the 51st Annual New Orleans Investment Conference GlobeNewswire October 28, 2025 VIRGINIA CITY, Nev., Oct. 28, 2025 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) today announced today that it will be participating as a Silver Sponsor at the 51st Annual New Orleans Investment Conference at the Hilton

Senator Susan Rubio Brings Civics to Life for Mt. SAC Early College Academy Students

Senator Susan Rubio Brings Civics to Life for Mt. SAC Early College Academy Students GlobeNewswire October 28, 2025 West Covina, CA, Oct. 28, 2025 (GLOBE NEWSWIRE) — Students at Mt. SAC Early College Academy (MECA) recently experienced government in action as they welcomed California State Senator Susan Rubio of the 22nd Senate District for a

Capital Power declares dividends for its Common and Preference shares

Capital Power declares dividends for its Common and Preference shares GlobeNewswire October 28, 2025 EDMONTON, Alberta, Oct. 28, 2025 (GLOBE NEWSWIRE) — The Board of Directors for Capital Power Corporation (“Capital Power”) (TSX: CPX) declared a dividend of $0.6910 per share on the outstanding common shares for the quarter ending December 31, 2025. The dividend

AVITA Medical Welcomes Support for RECELL(R) in Burns in Australia

AVITA Medical Welcomes Support for RECELL(R) in Burns in Australia GlobeNewswire October 28, 2025 Australia's Medical Services Advisory Committee (MSAC) recognizes RECELL(R) as safe and effective, with benefits in healing, donor site sparing, and reduced hospital stays VALENCIA, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or

Meritage Homes reports third quarter 2025 results

Meritage Homes reports third quarter 2025 results GlobeNewswire October 28, 2025 SCOTTSDALE, Ariz., Oct. 28, 2025 (GLOBE NEWSWIRE) — Meritage Homes Corporation (NYSE: MTH), the fifth-largest U.S. homebuilder, reported third quarter results for the period ended September 30, 2025. Summary Operating Results (unaudited)(Dollars in thousands, except per share amounts) Three Months Ended September 30, Nine

Scroll to Top